Structural basis and mode of action for two broadly neutralizing antibodies against SARS-CoV-2 emerging variants of concern

Anand, 2020, Interaction of human ACE2 to membrane-bound SARS-CoV-1 and SARS-CoV-2 S glycoproteins, Viruses, 12, 1104, 10.3390/v12101104 Anthony, 2017, Further evidence for bats as the evolutionary Source of Middle East respiratory syndrome coronavirus, mBio, 8, 10.1128/mBio.00373-17 Baden, 2020, Efficacy and safety of the mRNA-1273 SARS-CoV-2 vaccine, New Engl. J. Med., 384, 403, 10.1056/NEJMoa2035389 Barad, 2015, EMRinger: side chain–directed model and map validation for 3D cryo-electron microscopy, Nat. Methods, 12, 943, 10.1038/nmeth.3541 Barnes, 2020, Structures of human antibodies bound to SARS-CoV-2 spike reveal common epitopes and recurrent features of antibodies, Cell, 182, 828, 10.1016/j.cell.2020.06.025 Beaudoin-Bussières, 2020, Decline of humoral responses against SARS-CoV-2 spike in convalescent individuals, mBio, 11, 10.1128/mBio.02590-20 Burnley, 2017, Recent developments in the CCP-EM software suite, Acta Crystallogr. Section D, 73, 469, 10.1107/S2059798317007859 Cai, 2020, Distinct conformational states of SARS-CoV-2 spike protein, Science, 369, 1586, 10.1126/science.abd4251 Campbell, 2021, Increased transmissibility and global spread of SARS-CoV-2 variants of concern as at June 2021, Eurosurveillance, 26, 10.2807/1560-7917.ES.2021.26.24.2100509 Chen, 2021, Computational prediction of the effect of amino acid changes on the binding affinity between SARS-CoV-2 spike RBD and human ACE2, Proc. Natl. Acad. Sci, 118, 10.1073/pnas.2106480118 Chen, 2010, MolProbity: all-atom structure validation for macromolecular crystallography, Acta Crystallogr. Section D, 66, 12, 10.1107/S0907444909042073 Dejnirattisai, 2021, The antigenic anatomy of SARS-CoV-2 receptor binding domain, Cell, 184, 2183, 10.1016/j.cell.2021.02.032 Dieterle, 2020, A replication-competent vesicular stomatitis virus for studies of SARS-CoV-2 spike-mediated cell entry and its inhibition, Cell Host & Microbe, 28, 486, 10.1016/j.chom.2020.06.020 Dong, 2020, An interactive web-based dashboard to track COVID-19 in real time, Lancet Infect. Dis., 20, 533, 10.1016/S1473-3099(20)30120-1 Du, 2021, Structures of SARS-CoV-2 B.1.351 neutralizing antibodies provide insights into cocktail design against concerning variants, Cell Res., 31, 1130, 10.1038/s41422-021-00555-0 Dunbar, 2016, SAbPred: a structure-based antibody prediction server, Nucleic Acids Res., 44, W474, 10.1093/nar/gkw361 Emsley, 2004, Coot: model-building tools for molecular graphics, Acta Crystallogr. D Biol. Crystallogr., 60, 2126, 10.1107/S0907444904019158 Folegatti, 2020, Safety and immunogenicity of the ChAdOx1 nCoV-19 vaccine against SARS-CoV-2: a preliminary report of a phase 1/2, single-blind, randomised controlled trial, The Lancet, 396, 467, 10.1016/S0140-6736(20)31604-4 Ge, 2021, Antibody neutralization of SARS-CoV-2 through ACE2 receptor mimicry, Nat. Commun., 12, 250, 10.1038/s41467-020-20501-9 Ge, 2013, Isolation and characterization of a bat SARS-like coronavirus that uses the ACE2 receptor, Nature, 503, 535, 10.1038/nature12711 Gobeil, 2021, Effect of natural mutations of SARS-CoV-2 on spike structure, conformation, and antigenicity, Science, 10.1126/science.abi6226 Goddard, 2018, UCSF ChimeraX: Meeting modern challenges in visualization and analysis, Protein Sci., 27, 14, 10.1002/pro.3235 Greaney, 2021, Comprehensive mapping of mutations in the SARS-CoV-2 receptor-binding domain that affect recognition by polyclonal human plasma antibodies, Cell Host & Microbe, 29, 463, 10.1016/j.chom.2021.02.003 Greaney, 2021, Complete mapping of mutations to the SARS-CoV-2 spike receptor-binding domain that escape antibody recognition, Cell Host & Microbe, 29, 44, 10.1016/j.chom.2020.11.007 Grifoni, 2020, A sequence homology and bioinformatic approach can predict candidate targets for immune responses to SARS-CoV-2, Cell Host & Microbe, 27, 671, 10.1016/j.chom.2020.03.002 Hagen, 2017, Implementation of a cryo-electron tomography tilt-scheme optimized for high resolution subtomogram averaging, J. Struct. Biol., 197, 191, 10.1016/j.jsb.2016.06.007 Hastie, 2021, Defining variant-resistant epitopes targeted by SARS-CoV-2 antibodies: A global consortium study, Science, 374, 472, 10.1126/science.abh2315 Hoffmann, 2021, SARS-CoV-2 variants B.1.351 and P.1 escape from neutralizing antibodies, Cell, 184, 2384, 10.1016/j.cell.2021.03.036 Hoffmann, 2020, SARS-CoV-2 cell entry depends on ACE2 and TMPRSS2 and is blocked by a clinically proven protease inhibitor, Cell, 181, 271, 10.1016/j.cell.2020.02.052 Hsieh, 2020, Structure-based design of prefusion-stabilized SARS-CoV-2 spikes, Science, 369, 1501, 10.1126/science.abd0826 Hurlburt, 2021, Structural definition of a pan-sarbecovirus neutralizing epitope on the spike S2 subunit, bioRxiv Jennewein, 2021, Isolation and characterization of cross-neutralizing coronavirus antibodies from COVID-19 + subjects, Cell Rep., 36, 10.1016/j.celrep.2021.109353 Jette, 2021, Broad cross-reactivity across sarbecoviruses exhibited by a subset of COVID-19 donor-derived neutralizing antibodies, Cell Rep., 36, 109760, 10.1016/j.celrep.2021.109760 Ju, 2020, Human neutralizing antibodies elicited by SARS-CoV-2 infection, Nature, 584, 115, 10.1038/s41586-020-2380-z Juette, 2016, Single-molecule imaging of non-equilibrium molecular ensembles on the millisecond timescale, Nature Methods, 13, 341, 10.1038/nmeth.3769 Ke, 2020, Structures and distributions of SARS-CoV-2 spike proteins on intact virions, Nature, 588, 498, 10.1038/s41586-020-2665-2 Krissinel, 2007, Inference of macromolecular assemblies from crystalline state, J. Mol. Biol., 372, 774, 10.1016/j.jmb.2007.05.022 Lan, 2020, Structure of the SARS-CoV-2 spike receptor-binding domain bound to the ACE2 receptor, Nature, 581, 215, 10.1038/s41586-020-2180-5 Laumaea, 2020, Opening the HIV envelope: potential of CD4 mimics as multifunctional HIV entry inhibitors, Curr. Opin. HIV AIDS, 15, 300, 10.1097/COH.0000000000000637 Letko, 2020, Functional assessment of cell entry and receptor usage for SARS-CoV-2 and other lineage B betacoronaviruses, Nat. Microbiol., 5, 562, 10.1038/s41564-020-0688-y Li, 2021, Potent SARS-CoV-2 neutralizing antibodies with protective efficacy against newly emerged mutational variants, Nat. Commun., 12, 6304, 10.1038/s41467-021-26539-7 Li, 2021, Cross-neutralizing antibodies bind a SARS-CoV-2 cryptic site and resist circulating variants, Nat. Commun., 12, 5652, 10.1038/s41467-021-25997-3 Li, 2003, Angiotensin-converting enzyme 2 is a functional receptor for the SARS coronavirus, Nature, 426, 450, 10.1038/nature02145 Li, 2020, Subnanometer structures of HIV-1 envelope trimers on aldrithiol-2-inactivated virus particles, Nat. Struct. Mol. Biol., 27, 726, 10.1038/s41594-020-0452-2 Liebschner, 2019, Macromolecular structure determination using X-rays, neutrons and electrons: recent developments in Phenix, Acta Crystallogr. D Struct. Biol., 75, 861, 10.1107/S2059798319011471 Liu, 2020, Potent neutralizing antibodies against multiple epitopes on SARS-CoV-2 spike, Nature, 584, 450, 10.1038/s41586-020-2571-7 Liu, 2021, Identification of SARS-CoV-2 spike mutations that attenuate monoclonal and serum antibody neutralization, Cell Host & Microbe, 29, 477, 10.1016/j.chom.2021.01.014 Logunov, 2021, Safety and efficacy of an rAd26 and rAd5 vector-based heterologous prime-boost COVID-19 vaccine: an interim analysis of a randomised controlled phase 3 trial in Russia, The Lancet, 397, 671, 10.1016/S0140-6736(21)00234-8 Long, 2021, A non-RBM targeted RBD specific antibody neutralizes SARS-CoV-2 inducing S1 shedding, Biochem. Biophysical Res. Commun., 571, 152, 10.1016/j.bbrc.2021.07.062 Lopéz-Blanco, 2013, iMODFIT: Efficient and robust flexible fitting based on vibrational analysis in internal coordinates, J. Struct. Biol., 184, 261, 10.1016/j.jsb.2013.08.010 Lu, 2019, Associating HIV-1 envelope glycoprotein structures with states on the virus observed by smFRET, Nature, 568, 415, 10.1038/s41586-019-1101-y Lu, 2020, Real-time conformational dynamics of SARS-CoV-2 spikes on virus particles, Cell Host & Microbe, 28, 880, 10.1016/j.chom.2020.11.001 Ma, 2020, Cross-reactivity towards SARS-CoV-2: the potential role of low-pathogenic human coronaviruses, The Lancet Microbe, 1, e151, 10.1016/S2666-5247(20)30098-7 Mastronarde, 2005, Automated electron microscope tomography using robust prediction of specimen movements, J. Struct. Biol., 152, 36, 10.1016/j.jsb.2005.07.007 Mastronarde, 2017, Automated tilt series alignment and tomographic reconstruction in IMOD, J. Struct. Biol., 197, 102, 10.1016/j.jsb.2016.07.011 McCallum, 2021, N-terminal domain antigenic mapping reveals a site of vulnerability for SARS-CoV-2, Cell, 184, 2332, 10.1016/j.cell.2021.03.028 Menachery, 2015, A SARS-like cluster of circulating bat coronaviruses shows potential for human emergence, Nat. Med., 21, 1508, 10.1038/nm.3985 Menachery, 2016, SARS-like WIV1-CoV poised for human emergence, Proc. Natl. Acad. Sci., 113, 3048, 10.1073/pnas.1517719113 Minor, 2006, HKL-3000: the integration of data reduction and structure solution--from diffraction images to an initial model in minutes, Acta Crystallogr. D Biol. Crystallogr., 62, 859, 10.1107/S0907444906019949 Montefiori, 2021, SnapShot: SARS-CoV-2 antibodies, Cell Host & Microbe, 29, 1162, 10.1016/j.chom.2021.06.005 Munro, 2014, Conformational dynamics of single HIV-1 envelope trimers on the surface of native virions, Science, 346, 759, 10.1126/science.1254426 Ng, 2020, Preexisting and de novo humoral immunity to SARS-CoV-2 in humans, Science, 370, 1339, 10.1126/science.abe1107 Nguyen, 2021, Spike glycoprotein and host cell determinants of SARS-CoV-2 entry and cytopathic effects, J. Virol., 95, e02304, 10.1128/JVI.02304-20 Ou, 2020, Characterization of spike glycoprotein of SARS-CoV-2 on virus entry and its immune cross-reactivity with SARS-CoV, Nat. Commun., 11, 1620, 10.1038/s41467-020-15562-9 Pettersen, 2004, UCSF Chimera—a visualization system for exploratory research and analysis, J. Comput. Chem., 25, 1605, 10.1002/jcc.20084 Pettersen, 2021, UCSF ChimeraX: Structure visualization for researchers, educators, and developers, Protein Sci., 30, 70, 10.1002/pro.3943 Pinto, 2021, Broad betacoronavirus neutralization by a stem helix–specific human antibody, Science, 373, 1109, 10.1126/science.abj3321 Planas, 2021, Sensitivity of infectious SARS-CoV-2 B.1.1.7 and B.1.351 variants to neutralizing antibodies, Nat. Med., 27, 917, 10.1038/s41591-021-01318-5 Planas, 2021, Reduced sensitivity of SARS-CoV-2 variant Delta to antibody neutralization, Nature, 596, 276, 10.1038/s41586-021-03777-9 Polack, 2020, Safety and efficacy of the BNT162b2 mRNA covid-19 vaccine, New Engl. J. Med., 383, 2603, 10.1056/NEJMoa2034577 Prévost, 2021, The great escape? SARS-CoV-2 variants evading neutralizing responses, Cell Host & Microbe, 29, 322, 10.1016/j.chom.2021.02.010 Prévost, 2020, Cross-sectional evaluation of humoral responses against SARS-CoV-2 spike, Cell Rep. Med, 1 Punjani, 2017, cryoSPARC: algorithms for rapid unsupervised cryo-EM structure determination, Nat. Methods, 14, 290, 10.1038/nmeth.4169 Rappazzo, 2021, Broad and potent activity against SARS-like viruses by an engineered human monoclonal antibody, Science, 371, 823, 10.1126/science.abf4830 Robbiani, 2020, Convergent antibody responses to SARS-CoV-2 in convalescent individuals, Nature, 584, 437, 10.1038/s41586-020-2456-9 Rubinstein, 2015, Alignment of cryo-EM movies of individual particles by optimization of image translations, J. Struct. Biol., 192, 188, 10.1016/j.jsb.2015.08.007 Sadoff, 2021, Safety and efficacy of single-dose Ad26.COV2.S vaccine against covid-19, New Engl. J. Med., 384, 2187, 10.1056/NEJMoa2101544 Sadoff, 2021, Interim results of a phase 1–2a trial of Ad26.COV2.S covid-19 vaccine, New Engl. J. Med., 384, 1824, 10.1056/NEJMoa2034201 Sauer, 2021, Structural basis for broad coronavirus neutralization, Nat. Struct. Mol. Biol., 28, 478, 10.1038/s41594-021-00596-4 Schmidt, 2020, Measuring SARS-CoV-2 neutralizing antibody activity using pseudotyped and chimeric virusesSARS-CoV-2 neutralizing antibody activity, J. Exp. Med, 217, 10.1084/jem.20201181 Shang, 2020, Structural basis of receptor recognition by SARS-CoV-2, Nature, 581, 221, 10.1038/s41586-020-2179-y Skowronski, 2021, Single-dose mRNA vaccine effectiveness against SARS-CoV-2, including Alpha and Gamma variants: a test-negative design in adults 70 years and older in British Columbia, Canada, Clin. Infect. Dis Song, 2021, Cross-reactive serum and memory B-cell responses to spike protein in SARS-CoV-2 and endemic coronavirus infection, Nat. Commun., 12, 2938, 10.1038/s41467-021-23074-3 Starr, 2021, Prospective mapping of viral mutations that escape antibodies used to treat COVID-19, Science, 371, 850, 10.1126/science.abf9302 Starr, 2020, Deep mutational scanning of SARS-CoV-2 receptor binding domain reveals constraints on folding and ACE2 binding, Cell, 182, 1295, 10.1016/j.cell.2020.08.012 Tauzin, 2021, A single dose of the SARS-CoV-2 vaccine BNT162b2 elicits Fc-mediated antibody effector functions and T cell responses, Cell Host & Microbe, 29, 1137, 10.1016/j.chom.2021.06.001 Tian, 2020, Potent binding of 2019 novel coronavirus spike protein by a SARS coronavirus-specific human monoclonal antibody, Emerging Microbes & Infections, 9, 382, 10.1080/22221751.2020.1729069 Tortorici, 2020, Ultrapotent human antibodies protect against SARS-CoV-2 challenge via multiple mechanisms, Science, 370, 950, 10.1126/science.abe3354 Tortorici, 2021, Broad sarbecovirus neutralization by a human monoclonal antibody, Nature, 597, 103, 10.1038/s41586-021-03817-4 Turoňová, 2020, In situ structural analysis of SARS-CoV-2 spike reveals flexibility mediated by three hinges, Science, 370, 203, 10.1126/science.abd5223 Ullah, 2021, Live imaging of SARS-CoV-2 infection in mice reveals that neutralizing antibodies require Fc function for optimal efficacy, Immunity, 54, 2143, 10.1016/j.immuni.2021.08.015 Volz, 2021, Assessing transmissibility of SARS-CoV-2 lineage B.1.1.7 in England, Nature, 593, 266, 10.1038/s41586-021-03470-x Voysey, 2021, Safety and efficacy of the ChAdOx1 nCoV-19 vaccine (AZD1222) against SARS-CoV-2: an interim analysis of four randomised controlled trials in Brazil, South Africa, and the UK, The Lancet, 397, 99, 10.1016/S0140-6736(20)32661-1 Walls, 2020, Structure, function, and antigenicity of the SARS-CoV-2 spike glycoprotein, Cell, 181, 281, 10.1016/j.cell.2020.02.058 Walls, 2019, Unexpected receptor functional mimicry elucidates activation of coronavirus fusion, Cell, 176, 1026, 10.1016/j.cell.2018.12.028 Wang, 2020, A human monoclonal antibody blocking SARS-CoV-2 infection, Nat. Commun., 11, 2251, 10.1038/s41467-020-16256-y Wang, 2021, A conserved immunogenic and vulnerable site on the coronavirus spike protein delineated by cross-reactive monoclonal antibodies, Nat. Commun., 12, 1715, 10.1038/s41467-021-21968-w Wang, 2021, Ultrapotent antibodies against diverse and highly transmissible SARS-CoV-2 variants, Science, 373, 10.1126/science.abh1766 Wang, 2018, Serological evidence of bat SARS-related coronavirus infection in humans, China, Virologica Sinica, 33, 104, 10.1007/s12250-018-0012-7 Wec Anna, 2020, Broad neutralization of SARS-related viruses by human monoclonal antibodies, Science, 369, 731, 10.1126/science.abc7424 Weisblum, 2020, Escape from neutralizing antibodies by SARS-CoV-2 spike protein variants, eLife, 9, 10.7554/eLife.61312 Winkler, 2007, 3D reconstruction and processing of volumetric data in cryo-electron tomography, J. Struct. Biol., 157, 126, 10.1016/j.jsb.2006.07.014 Wrapp, 2020, Cryo-EM structure of the 2019-nCoV spike in the prefusion conformation, Science, 367, 1260, 10.1126/science.abb2507 Xiao, 2021, A trimeric human angiotensin-converting enzyme 2 as an anti-SARS-CoV-2 agent, Nat. Struct. Mol. Biol., 28, 202, 10.1038/s41594-020-00549-3 Xu, 2021, Conformational dynamics of SARS-CoV-2 trimeric spike glycoprotein in complex with receptor ACE2 revealed by cryo-EM, Sci. Adv, 7, 10.1126/sciadv.abe5575 Yamamoto, 2019, Cell–cell and virus–cell fusion assay–based analyses of alanine insertion mutants in the distal α9 portion of the JRFL gp41 subunit from HIV-1, J. Biol. Chem., 294, 5677, 10.1074/jbc.RA118.004579 Yao, 2020, Molecular architecture of the SARS-CoV-2 virus, Cell, 183, 730, 10.1016/j.cell.2020.09.018 Yu, 2021, Deletion of the SARS-CoV-2 spike cytoplasmic tail increases infectivity in pseudovirus neutralization assays, J. Virol., 95, 10.1128/JVI.00044-21 Zheng, 2017, MotionCor2: anisotropic correction of beam-induced motion for improved cryo-electron microscopy, Nat. Methods, 14, 331, 10.1038/nmeth.4193 Zhou, 2020, A pneumonia outbreak associated with a new coronavirus of probable bat origin, Nature, 579, 270, 10.1038/s41586-020-2012-7 Zhou, 2021, A protective broadly cross-reactive human antibody defines a conserved site of vulnerability on beta-coronavirus spikes, bioRxiv Zhu, 2020, A novel coronavirus from patients with pneumonia in China, 2019, New Engl. J. Med., 382, 727, 10.1056/NEJMoa2001017 Zost, 2020, Potently neutralizing and protective human antibodies against SARS-CoV-2, Nature, 584, 443, 10.1038/s41586-020-2548-6